Boston Scientific Corp
BSXToday
+1.81%
5 Days
+2.05%
1 Month
-3.04%
6 Months
-33.01%
Year to Date
-49.87%
1 Year
-55.42%
Brightspring Health Services Inc Stock (BTSG) Closed Up by 7.20% on Aug 26: Key Drivers Unveiled
• BrightSpring reported strong second-quarter revenue and raised its full-year guidance. • Wall Street analysts maintained buy ratings with an average price target of $78.97. • Annual revenue reached $12.91 billion with a net profit of $190.67 million.
HCA Healthcare Inc Stock (HCA) Moved Up by 5.35% on Aug 21: Drivers Behind the Movement
• HCA Healthcare reported strong quarterly operating results driven by robust patient admissions. • Institutional accumulation and strategic outpatient expansion reinforced positive investor sentiment and price momentum. • The company achieved annual revenue of $75.60B and net profit of $6.78B.
Stryker Corp Stock (SYK) Closed Down by 3.61% on Aug 20: A Full Analysis
• Stryker shares faced volatility and profit-taking despite securing a U.S. defense contract modification. • Investors remain cautious regarding operational disruptions, cyber incident costs, and supply chain bottlenecks. • The company reported annual revenue of $25.12B and a net profit of $3.25B.
Intuitive Surgical Inc Stock (ISRG) Moved Down by 4.89% on Aug 20: What Signal Does It Send?
• Competitors received regulatory clearances, increasing market share concerns for Intuitive Surgical. • Management maintained conservative full-year guidance despite robust quarterly operational metrics. • Wall Street brokerages revised price targets downward due to hospital capital expenditure caution.
Cencora Inc Stock (COR) Closed Down by 5.92% on Aug 12: Key Drivers Unveiled
• Cencora stock fell as non-prime Walgreens pharmaceutical volume moved to competitors. • Investors focused on revenue risks despite reiterated full-year earnings per share guidance. • Cencora reported $321.33B in annual revenue, ranking first in its industry.
Intuitive Surgical Inc Stock (ISRG) Moved Up by 3.01% on Aug 10: A Full Analysis
• Intuitive Surgical shares rose due to increased global procedure volumes and institutional demand. • Stable hospital capital expenditure and recurring revenue models support the company’s financial growth. • Analysts maintain a Buy rating with an average price target of $480.08.
Boston Scientific Corp's Score
Media Coverage
Analyst Rating
Boston Scientific Corp Technical Analysis
Technical Indicators
Summary
Moving Average
Financial Indicators
Earnings
Boston Scientific Corp Profile
Ownership
| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.49% |
| Fidelity Management & Research Company LLC | 5.85% |
| BlackRock Institutional Trust Company, N.A. | 5.40% |
| State Street Investment Management (US) | 4.43% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 51.83% |
| Investment Advisor/Hedge Fund | 26.29% |
| Hedge Fund | 6.11% |
| Pension Fund | 3.03% |
Related Instruments
Popular Instruments
